A new intranasal delivery system shows promise in reducing neuroinflammation and slowing the progression of multiple sclerosis. Read More
A study of four drugs to combat chronic neuropathic pain finds Nortriptyline has the highest efficacious percentage and lowest quit rate. Read More
Recovery from multiple sclerosis-like symptoms in mice depends upon the ability for microglia to break down the remains of damaged cells. Read More
People who experience severe apathy have a significantly higher risk of developing dementia, a new study reports. Read More
New artificial intelligence technology will analyze clinical data, brain images, and genetic information from Alzheimer's patients to look for new biomarkers associated with the neurodegenerative disease. Read More
Parkinson's patients carrying mutations in PINK1 and Parkin genes have increased levels of circulating interleukin 6 and mitochondrial DNA. The findings strengthen a link between genetic risk factors from Parkinson's disease and inflammation. Read More
By fusing a cytokine to a blood protein, researchers have developed a new therapy to help treat multiple sclerosis. Read More
Impaired blood flow to specific areas of the brain coincides with Tau buildup in Alzheimer's patients. As cognition declines, the relationship between vascular dysfunction and Tau accumulation strengthens. Read More
MP-Pt(IV), a second generation prodrug appears to have curative properties against glioblastoma when coupled with chemotherapy in mouse models. Read More
N-acetylglucosamine, a simple sugar found in breast milk, promotes remyelination in mouse models of multiple sclerosis. The findings could have implications for treating multiple sclerosis in humans. Read More
Researchers report there is no increased risk of being diagnosed with dementia in those who received general anesthesia compared to those who didn't. Read More
The Alzheimer's risk gene ApoE4 hampers the process of endocytosis in astrocytes. Read More
